Direct evaluation of progression or regression of disease burden in brain metastatic disease with Deep Neuroevolution
Purpose: A core component of advancing cancer treatment research is assessing response to therapy. Doing so by hand, for example as per RECIST or RANO criteria, is tedious, time-consuming, and can miss important tumor response information; most notably, they exclude non-target lesions. We wish to assess change in a holistic fashion that includes all lesions, obtaining simple, informative, and automated assessments of tumor progression or regression. Due to often low patient enrolments in clinical trials, we wish to make response assessments with small training sets. Deep neuroevolution (DNE) can produce radiology artificial intelligence (AI) that performs well on small training sets. Here we use DNE for function approximation that predicts progression versus regression of metastatic brain disease. Methods: We analyzed 50 pairs of MRI contrast-enhanced images as our training set. Half of these pairs, separated in time, qualified as disease progression, while the other 25 images constituted regression. We trained the parameters of a relatively small CNN via mutations that consisted of random CNN weight adjustments and mutation fitness. We then incorporated the best mutations into the next generations CNN, repeating this process for approximately 50,000 generations. We applied the CNNs to our training set, as well as a separate testing set with the same class balance of 25 progression and 25 regression images. Results: DNE achieved monotonic convergence to 100% training set accuracy. DNE also converged monotonically to 100% testing set accuracy. Conclusion: DNE can accurately classify brain-metastatic disease progression versus regression. Future work will extend the input from 2D image slices to full 3D volumes, and include the category of no change. We believe that an approach such as our could ultimately provide a useful adjunct to RANO/RECIST assessment.
Code (0)
등록된 구현이 없습니다.
Tasks
regressionSimilar Papers 제목 키워드 기반
Directed Ordinal Diffusion Regularization for Progression-Aware Diabetic Retinopathy Grading
Diabetic Retinopathy (DR) progresses as a continuous and irreversible deterioration of the retina, following a well-defined clinical trajectory from mild to severe stages. However, most existing ordinal regression approa…
Diabetic Retinopathy GradingIntegrated Machine Learning and Survival Analysis Modeling for Enhanced Chronic Kidney Disease Risk Stratification
Chronic kidney disease (CKD) is a significant public health challenge, often progressing to end-stage renal disease (ESRD) if not detected and managed early. Early intervention, warranted by silent disease progression, c…
Feature ImportanceSurvival AnalysisLongitudinal Quantitative Assessment of COVID-19 Infection Progression from Chest CTs
Chest computed tomography (CT) has played an essential diagnostic role in assessing patients with COVID-19 by showing disease-specific image features such as ground-glass opacity and consolidation. Image segmentation met…
Computed Tomography (CT)COVID-19 Image SegmentationDiagnosticImage Segmentation+1Learning Directional Semantic Transitions for Longitudinal Chest X-ray Analysis
Chest X-ray (CXR) interpretation often requires longitudinal comparison to assess disease progression. Existing approaches typically rely on temporal feature fusion or inter-study discrepancy modeling, yet remain limited…
Trajectory ModelingMicrobiome and metabolome insights into the role of the gastrointestinal-brain axis in neurodegenerative diseases: unveiling potential therapeutic targets
Due to the aging of the world population and westernization of lifestyles, the prevalence of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) is rapidly rising and is expected to p…